Medicare Enrolled

Dr. Dania Masseoud, M.D.

Rheumatology · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3193 HOWELL MILL RD NW, Atlanta, GA 30327
4046039090
Registered in NPPES since 2006
NPI: 1568471258 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Masseoud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Masseoud? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Masseoud

Dr. Dania Masseoud is a rheumatology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Masseoud performed 14,259 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Masseoud received a total of $15,840 from 69 pharmaceutical and/or device companies across 895 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Masseoud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 27% volume in GA $15,840 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
14,259
Medicare services
Top 27% in GA for rheumatology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
12,350 $10 $71
Denosumab injection (Prolia/Xgeva) 1,320 $18 $81
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
301 $59 $152
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
171 $97 $614
New patient office visit, complex (60-74 min) 64 $153 $500
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
32 $53 $309
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
21 $10 $99
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
87.8% high complexity
9.6% medium
2.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,840
Total received (2018-2024)
Avg $2,263/year across 7 years
Top 22% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
895
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,677
2023
$2,911
2022
$2,475
2021
$1,928
2020
$1,513
2019
$2,265
2018
$2,070

Payments by company (2024)

Amgen Inc.
$468
ABBVIE INC.
$285
AstraZeneca Pharmaceuticals LP
$212
Janssen Biotech, Inc.
$200
PFIZER INC.
$195
Novartis Pharmaceuticals Corporation
$174
GlaxoSmithKline, LLC.
$154
UCB, Inc.
$143
Mallinckrodt Hospital Products Inc.
$134
Collegium Pharmaceutical, Inc.
$110
ANI Pharmaceuticals, Inc.
$83
E.R. Squibb & Sons, L.L.C.
$82
Lundbeck LLC
$74
SOBI, INC
$68
GENZYME CORPORATION
$48
Fresenius Kabi USA, LLC
$40
Organon Llc
$39
IDORSIA PHARMACEUTICALS US INC
$35
Lilly USA, LLC
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Alexion Pharmaceuticals, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$21
Curonix LLC
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Top 3 companies account for 36.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,389
ABBVIE INC.
$1,342
Janssen Biotech, Inc.
$1,308
Novartis Pharmaceuticals Corporation
$1,274
PFIZER INC.
$1,165
UCB, Inc.
$1,010
Horizon Therapeutics plc
$668
AstraZeneca Pharmaceuticals LP
$633
AbbVie Inc.
$564
Mallinckrodt Hospital Products Inc.
$559
AbbVie, Inc.
$433
GlaxoSmithKline, LLC.
$382
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$267
Lilly USA, LLC
$260
Collegium Pharmaceutical, Inc.
$247
SANOFI-AVENTIS U.S. LLC
$236
Biohaven Pharmaceuticals, Inc.
$228
GENZYME CORPORATION
$171
Lundbeck LLC
$163
E.R. Squibb & Sons, L.L.C.
$159
Boehringer Ingelheim Pharmaceuticals, Inc.
$141
Sobi, Inc
$141
Horizon Pharma plc
$140
Celgene Corporation
$138
Genentech USA, Inc.
$116
SOBI, INC
$115
ANI Pharmaceuticals, Inc.
$106
Mallinckrodt Enterprises LLC
$96
Biohaven Pharmaceutical Holding Company Ltd.
$93
Sandoz Inc.
$81
TerSera Therapeutics LLC
$78
Eisai Inc.
$76
Teva Pharmaceuticals USA, Inc.
$70
BioDelivery Sciences International, Inc.
$67
IDORSIA PHARMACEUTICALS US INC
$56
Boston Scientific Corporation
$56
Flexion Therapeutics, Inc.
$49
FIDIA PHARMA USA INC.
$47
Mallinckrodt LLC
$44
Bioventus LLC
$41
Fresenius Kabi USA, LLC
$40
DePuy Synthes Sales Inc.
$40
Organon Llc
$39
MEDEXUS PHARMA, INC.
$38
Merck Sharp & Dohme Corporation
$34
Assertio Therapeutics, Inc.
$30
Shionogi Inc
$28
Aurinia Pharma U.S., Inc.
$25
RedHill Biopharma Inc.
$25
Bausch Health US, LLC
$23
Purdue Pharma L.P.
$23
EISAI INC.
$22
Alexion Pharmaceuticals, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$21
IMPEL PHARMACEUTICALS INC.
$20
Mylan Institutional Inc.
$18
Octapharma USA, Inc.
$18
Scilex Pharmaceuticals Inc.
$18
Azurity Pharmaceuticals, Inc.
$17
Curonix LLC
$16
Organon LLC
$14
Kaleo, Inc.
$14
MEDAC PHARMA, INC.
$14
Shire North American Group Inc
$13
Zyla Life Sciences
$13
Daiichi Sankyo Inc.
$12
Mission Pharmacal Company
$12
Egalet US Inc
$12
Pernix Therapeutics Holdings, Inc.
$12
Top 3 companies account for 31.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMJEVITA · Actemra · Aimovig · Aquoral · BELBUCA · BELSOMRA · BENLYSTA · BUNAVAIL 2.1 mg 30-count box · Bimzelx · COSENTYX · Cambia · Cimzia · DUEXIS · Dayvigo · Durolane · EVENITY · EVZIO · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · HUMIRA · HYALGAN · HYRIMOZ · Horizant · Humira · Hymovis · IDACIO · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MIGRANAL · MOVANTIK · Morphabond ER · Movantik · NUCALA · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · OXAYDO · Otezla · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · RELISTOR ORAL · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRIX · STELARA · STRENSIQ · SYMPROIC · Symproic · TALTZ · TAVNEOS · TREMFYA · TRINTELLIX · Trudhesa · Tyenne · VYEPTI · XELJANZ · XTAMPZA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Atlanta?
Compare rheumatologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
87
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
2.6 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Masseoud is a mixed practice specialist, with above-average Medicare volume (top 27% in GA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Masseoud experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Masseoud performed 12,350 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Masseoud receive payments from pharmaceutical companies?
Yes. Dr. Masseoud received a total of $15,840 from 69 companies across 895 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Masseoud's costs compare to other rheumatologists in Atlanta?
Dr. Masseoud's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Masseoud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →